Eli Lilly and Company News - October 29, 2026
🟢 Eli Lilly is trading 8% up today after raising 2026 revenue outlook
Eli Lilly is trading at $1392.02, up 8.05%, after strong demand for Mounjaro and Zepbound drove third-quarter results. - On October 29, 2026, Eli Lilly...
Eli Lilly's third quarter 2026 revenue of $24.4B beat estimates behind surging tirzepatide demand
Eli Lilly reported a significant top- and bottom-line beat for the third quarter 2026, driven by a 53% increase in total volume primarily from its obesity and...
🟢 Eli Lilly is trading 4.38% up in pre-market after retatrutide beats Ozempic in Phase 3 trial
Eli Lilly is trading at $1,344.79, up 4.38%, after Eli Lilly reported Wednesday that its investigational retatrutide outperformed Ozempic on blood-sugar...